Custovic Zajim, Kraus Ognjen, Tomaskovic Igor, Tarle Marko
Department of Urology, General Hospital Dubrovnik, Roka Misetica Street, 20000 Croatia.
Anticancer Res. 2007 Jul-Aug;27(4C):2817-21.
Serum levels of total prostate specific antigen (t-PSA) and PSA complexed to antichymotrypsin (PSA-ACT), as well as their corresponding density parameters were measured in prostate cancer (PC) candidates for radical prostatectomy. In these patients blood Chromogranin A (CgA) values were also recorded. The PSA-ACT recordings in presurgically characterized organ-confined disease were assumed to predict post-surgical staging better than t-PSA. If this proved correct the novel approach might contribute to the positive predictive value of Partin nomograms. In this prospective study 50 patients with clinically localized PC underwent staging pelvic lymphadenectomy and radical prostatectomy. The numerical values of the tPSA and PSA-ACT parameters were presurgically measured. The PSA and PSA-ACT densities (PSAD and ACTD) of the whole prostate were calculated by using transurethral ultrasound (TRUS) data. These preoperative results together with the CgA values were correlated with post-surgical pathological staging data. The relationships between serum tPSA, PSA-ACT, PSAD, ACTD, CgA and the final stage of prostatectomy specimens derived from the pathological data were analyzed. This preliminary study was performed on a relatively small number of patients who were characterized by a serum PSA <20 and a Gleason score (GS) < or =7. Nevertheless, the application of the logistic regression model showed both t-PSA and PSA-ACT to be superior to their density derivatives in predicting postsurgical pathological stage in PC patients who initially seemed to have localized prostate cancer. An elevation in serum CgA level, although rather infrequent at the early stages of PC is principally found in patients with higher Gleason score PC and was mostly associated with extracapsular tumor spread. Our results do not justify the substitution of PSA-ACT for t-PSA data in the Partin nomogram approach.
对拟行根治性前列腺切除术的前列腺癌(PC)患者,检测了血清总前列腺特异性抗原(t-PSA)水平、与抗胰凝乳蛋白酶结合的PSA(PSA-ACT)水平及其相应的密度参数。还记录了这些患者的血液嗜铬粒蛋白A(CgA)值。术前诊断为器官局限性疾病的患者,其PSA-ACT记录被认为比t-PSA能更好地预测术后分期。如果这一结论正确,这种新方法可能有助于提高Partin列线图的阳性预测值。在这项前瞻性研究中,50例临床局限性PC患者接受了盆腔淋巴结清扫术和根治性前列腺切除术。术前测量了tPSA和PSA-ACT参数的数值。利用经尿道超声(TRUS)数据计算了整个前列腺的PSA和PSA-ACT密度(PSAD和ACTD)。这些术前结果连同CgA值与术后病理分期数据进行了关联分析。分析了血清tPSA、PSA-ACT、PSAD、ACTD、CgA与病理数据得出的前列腺切除标本最终分期之间的关系。这项初步研究是在相对较少的患者中进行的,这些患者的血清PSA<20且Gleason评分(GS)<或=7。然而,逻辑回归模型的应用表明,在最初看似患有局限性前列腺癌的PC患者中,t-PSA和PSA-ACT在预测术后病理分期方面均优于其密度衍生物。血清CgA水平升高虽然在PC早期相当少见,但主要见于Gleason评分较高的PC患者,且大多与肿瘤包膜外扩散有关。我们的结果并不支持在Partin列线图方法中用PSA-ACT替代t-PSA数据。